News and Trends 17 Oct 2022 PerkinElmer’s Horizon Discovery: the lowdown on base editing …the human genome. However, the creation of double stranded DNA breaks (dsDNA), while central to the function of the “bacterial immune system” from which CRISPR was derived, is not ideal… October 17, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 27 Aug 2024 Could microbiome drugs be the key to unlocking checkpoint inhibitors’ potential? …focus is similar to Microbiotica’s and its pipeline is still mostly preclinical. Genome & Company Genome & Company, headquartered in South Korea, is focusing on combining microbiome modulators with established… August 27, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2018 This is Why You Should Avoid Eating too Much Junk Food …the genome of immune progenitor cells, leading to the increased production of monocytes and granulocytes – basophils, neutrophils, and eosinophils – in particular. The researchers then looked at the blood… January 15, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 1 Oct 2024 Lithuania’s biotech: Six companies to put on your radar …the imaginations of investors and companies across the life sciences space. The technology has made it simpler than ever to make precise changes to the genome for applications in the… October 1, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2022 CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded …services. Both companies will work together to offer “one-stop shop” CRISPR sublicensing solutions, providing Sigma-Aldrich CRISPR IP rights for both mammalian cells and the rodent animal field. Sigma-Aldrich genome editing… September 8, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 26 Aug 2022 Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics …by Robert Coughlin, JLL managing director and New England Life Science Practice Group lead. Study says gene editing with CRISPR/Cas9 can lead to cell toxicity and genome instability CRISPR allows… August 26, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 15 Aug 2019 Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once …genome editing technique, CRISPR-Cas9, uses the DNA-cutting enzyme Cas9 and an RNA molecule that guides Cas9 where to cut on the genome. Instead of Cas9, this latest study published in… August 15, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jan 2018 European Court Supports the Softening of CRISPR Gene Editing Rules …in the genome by short pieces of ‘guide RNA’ CRISPR, which stands for clustered regularly interspaced short palindromic repeats, is used in combination with Cas9 nucleases for genome engineering, by… January 22, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 30 Dec 2020 A Look Back at the Past Decade of European Biotech …Europe. Meaning there is still a lot of space to grow. “Today we can get the entire human genome sequence in 24 hours for $500. This has opened up the… December 30, 2020 - 15 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2024 12 biotech unicorns revolutionizing the future of healthcare …of edits and insertions into the genome to deliver therapeutic genes. Tessera’s Gene Writing technology is based on a different concept to CRISPR called mobile genetic elements (MGEs). These are… October 10, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
More News! 17 Jul 2017 Israeli Biotech Partners with German Chem Giant to Develop Non-GMO Herbicide Resistance …with six genome copies, is the result of hybridizations between three species that had two genome copies each, which happened over 10,000 years ago. By multiplying the DNA load, Kaiima… July 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2025 Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology …Cas nucleases, G-dase E is the first to demonstrate a substantial cytotoxic effect in targeted cells, caused by the degradation of the genome. Contrary to Cas9-based editing events, G-dase E… February 4, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email